What Will Managed Markets Look Like Postpandemic?

Navigating a postpandemic market access landscape will require new perspectives and strategies.

Roshawn Blunt, managing director of 1798, a Fingerpaint company, spoke with Med Ad News about what managed market executives on both the pharma and agency sides will be facing.

“From a payer perspective, having to navigate those landscapes in certain areas where you might see far more dramatic swings—for example, a diabetic population that may have been covered by commercial insurance may have to swing somewhere else to get coverage—means you’re going to be thinking about your economics in a fundamentally different way,” Blunt told the publication. “How you’re going to be negotiating with manufacturers and other efforts that you’re doing are going to, by extension, change.”

For more of her perspective on the topic, read the full Med Ad News article or connect with her directly on LinkedIn.